Valuation : Cipher Pharmaceuticals Inc.

Market Cap 364M 263M 227M 213M 195M 24.87B 365M 2.52B 978M 12.76B 989M 968M 41.11B P/E 2026 *
12.8x
P/E 2027 * 11.5x
Enterprise Value 364M 263M 227M 213M 195M 24.87B 365M 2.52B 978M 12.76B 989M 968M 41.11B EV / Sales 2026 *
5.15x
EV / Sales 2027 * 4.42x
Free-Float
57.65%
Yield 2026 *
-
Yield 2027 * -
1 day-0.35%
1 week+2.80%
Current month+4.82%
1 month-15.25%
3 months-14.85%
6 months-2.65%
Current year-4.78%
1 week 13.58
Extreme 13.585
14.67
1 month 13.51
Extreme 13.51
18.46
Current year 13.51
Extreme 13.51
20.56
1 year 12.48
Extreme 12.48
20.56
3 years 4.1
Extreme 4.1
20.56
5 years 1.54
Extreme 1.54
20.56
10 years 0.38
Extreme 0.38
20.56
Manager TitleAgeSince
Chief Executive Officer - 2019-07-28
Director of Finance/CFO - 2024-08-09
Director of Finance/CFO - 2022-08-14
Director TitleAgeSince
Chairman - 2019-06-11
Director/Board Member 78 2023-06-20
Director/Board Member - 2023-06-20
Date Insider Type Main position Quantity % Market Cap. Importance
6/24/26 Option

Director

2,500 0.0098%
3/27/26 Option

Chief Executive Officer

83,902 0.3307%
3/27/26 Option

Chief Executive Officer

83,902 0.3307%
Change 5-day change 1-year change 3-year change Capi.($)
-0.35%+2.80%-10.49%+242.24% 263M
-0.88%-2.15%+58.05%+105.91% 1,024B
-1.15%+2.68%+54.25%+71.29% 663B
-1.44%+0.38%+20.65%+75.54% 453B
+0.14%-0.47%+30.20%+40.61% 352B
-1.33%+4.72%+24.62%+47.60% 304B
-1.15%+0.30%-0.69%+11.83% 252B
-1.55%+1.11%+54.15%+72.13% 236B
-0.88%+1.15%-14.60%-54.84% 206B
-0.15%+3.65%+31.24%+100.90% 187B
Average -0.87%+1.26%+24.74%+71.32% 367.86B
Weighted average by Cap. -0.96%+0.55%+37.63%+67.01%

Financials

2026 *2027 *
Net sales 70.77M 51.15M 44.02M 41.42M 37.83M 4.83B 70.97M 489M 190M 2.48B 192M 188M 7.98B 82.55M 59.67M 51.34M 48.31M 44.13M 5.63B 82.77M 571M 222M 2.89B 224M 219M 9.31B
Net income 27.53M 19.9M 17.13M 16.11M 14.72M 1.88B 27.61M 190M 73.88M 964M 74.73M 73.1M 3.11B 32.44M 23.45M 20.18M 18.98M 17.34M 2.21B 32.53M 224M 87.04M 1.14B 88.04M 86.12M 3.66B
Net Debt - -
Logo Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals Inc. is a Canada-based specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company acquires products, manages the required clinical development and regulatory approval process, and markets those products either directly or indirectly in Canada, the United States and South America. The Company's product categories include dermatology, hospital acute care, out‑licensed, and specialty medicine. Its dermatology products include Actikerall, Epuris, Vaniqa and Natroba. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Absorica (isotretinoin) is an oral retinoid. Durela, its specialty medicine, is an opioid analgesic indicated for the management of moderate to moderately severe pain in adults who require continuous treatment for several days or more. Its pipeline products include Piclidenoson CF-101, MOB-015 and DTR-001.
Employees
5
Date Price Change Volume
26-09-04 $14.34 -0.35% 20,378
26-09-03 $14.39 -1.03% 31,498
26-09-02 $14.54 +2.47% 39,195
26-09-01 $14.19 +3.73% 44,018
26-08-31 $13.68 -1.94% 32,207
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
14.34CAD
Average target price
19.95CAD
Spread / Average Target
+39.12%

Quarterly revenue - Rate of surprise